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DiphenylaminoindazoleAbstract The triphenylbismuth diacetate reacted selectively with different aminoindazole
derivatives in presence of copper diacetate to engender a new series of mono phenyl aminoindazole
compounds in good to high yields. Moreover, the same reagent with 4-chloro-2-methyl-2H-indazol-
7-amine led to a mixture of mono- and N,N-diphenylaminoindazoles. However, its combination
with 2H-indazol-4-amine provided only one N,1-diphenylaminoindazole compound.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Heterocycles constitute a family of substances particularly
important in organic chemistry because of their presence in a
large number of natural and synthetic molecules with varied
useful properties. They play a major role in many areas of
medicine, biology, agronomy, cosmetology, and are endowed
with diverse pharmaceutical activities (anti-parasitic, anti-
fungal, anti-inﬂammatory, psychotropic) (Yang and
Knochel, 2004; Boyer et al., 2000; Barton et al., 1987; Pinhey
et al., 1980). Indeed, many heterocyclic indazole therapeutic
effects are reported in the literature. For example, thecompound YC-1 (Fig. 1) is an activator of the soluble enzyme
guanylyl cyclase (Sopkova-De Oliveria-Santos et al., 2000),
whereas Rimonabant (Fig. 2) is an anorectic antiobesity drug
that reduces bodyweight and improves cardiovascular and
metabolic risk factors in non-diabetic overweight or obese
patients (Scheen et al., 2006).
On the other hand, the N-aryl hetero aromatic molecules
are interesting in stereo selective synthesis and challenging
because they reveal new pathways to obtain pharmaceutical
and agrochemical compounds. In the past few years, consider-
able importance has been attached to synthetic methods lead-
ing to indazole derivatives because of their biological
properties (Caron and Vazquez, 1999; Yeu et al., 2001; Sun
et al., 1997; Rodgers et al., 1996; Norman et al., 1996;
Yoshida et al., 1996; Robertson et al., 1990; Keppler and
Hartmann, 1994; Li et al., 2003; Collot et al., 1999; Batt
et al., 2000; Cerecetto et al., 2005; Aronov and Murcko,
2004; Chem et al., 2011; Hering et al., 2006; O’Reilly et al.,
2001; Ahabchane et al., 2001).
In this paper, we present a simple and efﬁcient synthetic
procedure developed to obtain mono and di-N-phenylamino
















Table 1 Yields of aminophenylindazolic 1a–12a obtained
from the compounds 1–12.
Entry Product NH2 NCH3 X Yield (%)
1 1a 4-NH2 1-CH3 7-H 62
2 2a 4-NH2 1-CH3 7-Cl 72
3 3a 4-NH2 2-CH3 7-H 97
4 4a 4-NH2 2-CH3 7-Cl 49
5 5a 5-NH2 1-CH3 4-H 84
6 6a 5-NH2 1-CH3 4-Cl 88
7 7a 5-NH2 2-CH3 4-H 79
8 8a 6-NH2 1-CH3 7-H 74
9 9a 6-NH2 2-CH3 7-H 66
10 10a 7-NH2 1-CH3 4-H 85
11 11a 7-NH2 1-CH3 4-Cl 85
12 12a 7-NH2 2-CH3 4-H 70
2 A. Miloudi et al.of the diacetate triphenylbismuth/copper diacetate system
(Barton et al., 1980; Miloudi et al., 2001, 2004).
2. Results and discussion
Along the course of this arylation synthesis, the amino indazole
group was obtained by reduction of the corresponding nitro
group with the Pd/H2 catalyst in presence of ethanol. The
amino and chloroamino indazole derivatives were obtained in
good yields with SnCl2/HCl in a solution of ethanol as products
functionalized in different positions (Miloudi et al., 2006).
The derivatives 1–12 were reacted with 1.1 equiv. of triphe-
nylbismuth diacetate in presence of a catalytic quantity of cop-
per diacetate (0.1 equiv) in methylene chloride (5-30 mL) at
room temperature. The reaction pathway is summarized in
Scheme 1.
The monophenyl compounds 1–9 were obtained with mod-
erate to good yields. The phenylation of the aminoindazoles by
the Ph3Bi(OAc)2/Cu(OAc)2 system led to the corresponding
monophenylated products with yields varying from 62% to
97%. The lowest yield of 49% was in each case achieved with
4-aminophenyl-7-chloro-2-methylindazolic 4 (Table 1).
It should be noted that the phenylation of the 7-amino-
4-chloro-2-methylindazole 13 by the same system led to a mix-
ture of mono and diphenylated compounds 13a and 13b,
respectively (Scheme 2). The latter products were isolated by
silica gel chromatography with a yield of 28% and 22%,
respectively.
Moreover, the reaction of 4-aminoindazole 14 with triphe-
nylbismuth diacetate led to 4-phenylamino-1-phenylindazole

























1 - 12 1a - 12a
Scheme 1 Phenylation of aminoindazole 1–12.
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Melting points were determined by the Bu¨chi Melting Point
apparatus and were not corrected. The 1H and 13C NMR spec-
tra were measured on a Bruker Avance 300 spectrometer oper-
ating at 300 MHz. Chemical shifts were recorded as units
relative to DMSO-d6 or CDCl3 as the solvent unless otherwise
stated, with J values in Hertz. Combustion analyses were per-
formed in the ‘‘Laboratoire deMicroanalyse du centre National
de la Recherche Scientiﬁque’’, Vernaison (France). Chromatog-
raphy separations were achieved on silica gel (Merck).
3.2. General procedure of N-phenylamin-indazole derivative
preparation
A mixture of the appropriate amino indazole (1 equiv.), triphe-
nylbismuth diacetate (1.1 equiv.) and copper diacetate
(0.1 equiv.) in dichloromethane solution of variable volume
according to the substrate was stirred at room temperature
during 5 h, unless otherwise stated. After ﬁltration of the solu-
tion, the solvent was distilled under reduced pressure to afford
oil which was then puriﬁed by chromatography on silica gel
with ether/pentane (1:1) eluent to supply N-phenylation prod-
ucts (Barton et al., 1978).
All the following compounds were obtained using the gen-
eral preparation procedure described above.
3.2.1. 1-Methyl-N-phenyl-1H-indazol-4-amine (1a)
Yield 62%, m.p. 102 C. 1H NMR (CDCl3): ppm 7.95 (s, 1H),
7.32 (s, 1H), 7.29 (s, 1H), 7.21 (d, J= 8.2, 1H), 7.04 (t,
J= 7.4, 1H), 6.90 (d, J= 7.5, 1H), 6.85 (s, 1H), 4.02 (s, 3H).
13C NMR (CDCl3): ppm 142.19, 141.34, 137.01, 130.22,
129.11, 127.40, 121.73, 119.21, 116.12, 104.75, 100.91, 35.40.
3.2.2. 7-Chloro-1-methyl-N-phenyl-1H-indazol-4-amine (2a)
Yield 72%, m.p. 85 C. 1H NMR (CDCl3): ppm 8.15 (s, 1H),
7.53 (t, J= 7.8, 2H), 7.37 (d, J= 8.1, 1H), 7.36 (d, J= 8.1,






























































Scheme 3 Phenylation of aminoindazole 14.
Phenylation of aminoindazole derivatives 31H), 4.56 (s, 3H). 13C NMR (CDCl3): ppm 141.76, 136.87,
135.97, 130.22, 129.18, 128.01, 121.98, 119.24, 118.61, 105.42,
100.60, 38.58.
3.2.3. 2-Methyl-N-phenyl-2H-indazol-4-amine (3a)
Yield 97%, m.p. 193 C. 1H NMR (DMSO-d6): ppm 8.49 (s,
1H), 8.16 (s, 1H), 7.29 (d, J= 8.1, 2H), 7.27 (t, J= 8.3,
2H), 7.20 (s, 1H), 7.04 (t, J= 7.4, 1H), 6.91 (t, J= 6.80,
1H), 6.89 (d, J= 8.30, 1H), 6.83 (d, J= 7.30, 1H), 3.98 (s,
3H). 13C NMR (CDCl3): ppm 141.72, 141.44, 136.25, 130.16,
128.83, 127.57, 121.53, 118.93, 116.22, 104.57, 100.71, 35.13.
3.2.4. 7-Chloro-2-methyl-N- phenyl-2H-indazol-4-amine (4a)
Yield 49%, m.p. 98 C. 1H NMR (CDCl3): ppm 7.70 (s, 1H),
7.25 (t, J= 8.5, 2H), 7.13 (d, J= 7.7, 1H), 7.03 (dd, J= 8.5,
J= 1.2, 2H), 6.95 (t, J= 7.3, 2H), 6.64 (d, J= 7.9, 1H), 4.09
(s, 3H). 13C NMR (CDCl3): ppm 146.95, 142.33, 135.15,
129.22, 126.11, 123, 88, 121.68, 118.87, 117.33, 113.32,
106.33, 40.39.
3.2.5. 1-Methyl-N-phenyl-1H-indazol-5- amine (5a)
Yield 84%, m.p. 150 C. 1H NMR (DMSO-d6) ppm 8.01 (s,
1H), 7.87 (s, 1H), 7.53 (d, J= 9.0, 1H), 7.40 (s, 1H), 7.20 (d,
J= 9.0, 1H), 7.17 (t, J= 6.0, 2H), 7.00 (d, J= 9.0, 2H),
6.74 (t, J= 9.0, 1H), 4.00 (s, 3H). 13C NMR (DMSO-d6):
ppm 145.59, 136.90, 136.55, 131.77, 129.59, 124.58, 121.91,
119.02, 115.64, 110.76, 108.78, 35.82.
3.2.6. 4-Chloro-1-methyl-N-phenyl-1H-indazol-5-amine (6a)
Yield 88%, m.p. 107 C. 1H NMR (DMSO-d6): ppm 7.99 (s,
1H), 7.75 (s, 1H), 7.59 (d, J= 8.9, 1H), 7.37 (d, J= 8.9,
1H), 7.15 (t, J= 7.5, 2H), 6.80 (d, J= 8.5, 2H), 6.73 (t,
J= 7.9, 1H), 4.05 (s, 3H). 13C NMR (CDCl3): ppm 149.50,
137.41, 132.36, 130.13, 129.00, 124.15, 123.41, 118.85, 116.39,
115.01, 109.49, 35.78.
3.2.7. 2-Methyl-N-phenyl-2H-indazol-5-amine (7a)
Yield 79%, m.p. 144 C. 1H NMR (DMSO-d6): ppm 8.06 (s,
1H), 7.97 (s, 1H), 7.51 (s, 1H), 7.26 (d, J= 9.0, 1H), 7.19 (t,
J= 7.6, 2H), 7.03 (d, J= 9.0, 1H), 7.02 (d, J= 7.4, 2H),Please cite this article in press as: Miloudi, A. et al., Phenylation of aminoindazol
j.arabjc.2014.08.0036.74 (t, J= 7.4, 1H), 4.09 (s, 3H). 13C NMR (DMSO-d6):
ppm 145.10, 144.78, 136.55, 129.04, 122.28, 118.64,
117.63(2C), 115.65, 112.84, 103.87, 39.76.
3.2.8. 1-Methyl-N-phenyl-1H-indazol-6-amine (8a)
Yield 74%, m.p. 143 C. 1H NMR (DMSO-d6): ppm 8.37 (s,
1H), 7.82 (s, 1H), 7.57 (s, 1H), 7.27 (t, J= 7.7, 1H), 7.18 (d,
J= 7.7, 1H), 7.12 (s, 1H), 6.88 (d, J= 8.6, 1H), 6.87 (t,
J= 7.7, 1H), 3.90 (s, 3H). 13C NMR (DMSO-d6): ppm
143.10, 142.42, 140.97, 132.18, 129.31, 121.44, 120.16, 118.12,
117.35, 114.28, 92.97, 35.12. Anal. calcd for C14H13N3. C:
75.34, H: 5.83, N: 18.83. Found. C: 75.14, H: 5.96, N: 18.65.
3.2.9. 2-Methyl-N-phenyl-2H-indazol-6-amine (9a)
Yield 66%, m.p. 144 C. 1H NMR (DMSO-d6): ppm 8.15 (s,
1H), 8.13 (s, 1H), 7.54 (d, J= 8.9, 1H), 7.23 (t, J= 7.5,
2H), 7.11 (s, 1H), 7.09 (d, J= 7.5, 2H), 6.81 (d, J= 7.4,
1H), 6.80 (t, J= 7.3, 1H), 4.04 (s, 3H). 13C NMR (DMSO-
d6): ppm 149.26, 143.72, 140.66, 129.13, 124.25, 120.94,
119.50, 117.19, 117.06, 116.76, 98.27, 39.50. Anal. calcd for
C14H13N3. C: 75.34, H: 5.83, N: 18.83. Found. C: 75.21, H:
5.98, N: 18.95.
3.2.10. 1-Methyl-N-phenyl-1H-indazol-7-amine (10a)
Yield 85%, m.p. 130 C. 1H NMR (DMSO-d6): ppm 8.07 (s,
1H), 7.78 (d, J= 7.7, 2H), 7.57 (d, J= 8.7, 2H), 7.21 (t,
J= 7.8, 2H), 7.13 (d, J= 7.8, 1H), 6.88 (t, J= 8.0, 1H),
6.75 (t, J= 7.4, 1H), 4.00 (s, 3H). 13C NMR (DMSO-d6):
ppm 147.50, 137.47, 135.20, 129.40, 124.25, 122.43, 122.20,
121.44, 121.25, 120.46, 115.15, 38.25.
3.2.11. 4-Chloro-1-methyl-N-phenyl-1H-indazol-7-amine (11a)
Yield 85%, m.p. 80 C. 1H NMR (DMSO-d6): ppm 8.06 (s,
1H), 7.15 (t, J= 7.4, 2H), 7.12 (d, J= 5.3, 1H), 7.08 (d,
J= 8.0, 1H), 6.77 (d, J= 7.8, 2H), 6.73 (t, J= 7.4, 1H),
4.10 (s, 3H). 13C NMR (DMSO-d6): ppm 147.04, 145.56,
136.88, 129.44, 124.80, 124.71, 122.06, 121.00, 120.99, 120.27,
115.15, 38.25.
3.2.12. 2-Methyl-N-phenyl-2H-indazol-7-amine (12a)
Yield 70%, m.p. 128–130 C. 1H NMR (DMSO-d6): ppm 8.40
(s, 1H), 7.54 (d, J= 8.0, 1H), 7.16–7.20 (m, 5H), 7.04 (d,
J= 7.8, 1H), 6.85 (t, J= 8.3, 1H), 4.12 (s, 3H). 13C NMR
(DMSO-d6): ppm 147.04, 145.21, 136.88, 129.32, 124.80,
122.59, 122.40, 122.06, 121.00, 120.66, 119.04, 40.02.
3.2.13. 4-Chloro-2-methyl-N-phenyl-2H-indazol-7-amine (13a)
and (13b)
Yield of 13a is 28%, m.p. 125 C. 1H NMR (DMSO-d6): ppm
8.43 (s, 1H), 7.20 (t, J= 7.6, 2H), 7.04 (d, J= 7.8, 1H), 6.91e derivatives. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/
4 A. Miloudi et al.(t, J= 7.9, 1H), 6.94 (d, J= 7.2, 2H), 6.85 (d, J= 7.7, 1H),
4.03 (s, 3H). 13C NMR (DMSO-d6): ppm 147.35, 145.01,
134.98, 129.08, 124.81, 123.43, 123.00, 122.36, 122.20, 120.46,
120.27, 40.35; and yield of 13b is 22%, m.p. 130 C. 1H
NMR (DMSO-d6): ppm 8.43 (s, 1H), 7.70 (d, J= 8.9, 2H),
7.39 (t, J = 8.9, 2H), 7.22 (t, J= 7.9, 1H), 7.19 (d, J= 7.6,
2H), 7.04 (d, J= 7.8, 1H), 6.94 (t, J= 7.9, 4H), 6.85 (d,
J= 7.7, 1H), 4.03 (s, 3H). 13C NMR (DMSO-d6): ppm
150.71, 147.52, 145.18, 135.17, 129.62, 129.25, 125.90, 125.00,
123.57, 123.25, 122.55, 122.35, 121.99, 121.18, 120.62, 40.51.
3.2.14. N,1-Diphenyl-1H-indazol-4-amine (14a)
Yield 23%, m.p. 170 C. 1H NMR (DMSO-d6): ppm 8.48 (s,
1H), 7.76 (d, J= 7.9, 2H), 7.59 (t, J= 7.2, 2H), 7.40 (t,
J= 7.0, 2H), 7.33 (d, J= 8.3, 2H), 7.29 (d, J= 8.1, 1H),
7.27 (d, J= 8.3, 1H), 7.24 (t, J= 8.3, 1H), 6.97 (t, J= 7.0,
1H), 6.92 (t, J= 8.3, 1H). 13C NMR (DMSO-d6): ppm
142.49, 140.11, 139.96, 137.93, 134.22, 129.77, 129.61, 129.39,
126.59, 122.31, 121.49, 119.29, 116.99, 104.29, 101.27.
4. Conclusion
We may conclude that pentavalent triphenylbismuth diacetate
appears to be a promising reagent for a novel source of C-N
bond formation with high efﬁciency on the primary amines
of indazole derivatives to provide the mono- and/or dipheny-
lated compounds with good yields. Moreover, it should be
noted that the efﬁciency of this arylating agent is improved
by the presence of the copper diacetate catalyst.
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